Literature DB >> 21291733

Metabolic syndrome and dyslipidemia in youth.

Catherine McNeal1, Don P Wilson.   

Abstract

Obesity is a well-known risk factor for metabolic syndrome. Although the cause or causes of metabolic syndrome are debated, insulin resistance, dyslipidemia, and hypertension are increasingly recognized in children and adolescents, especially those who are overweight or obese. Although adoption of a healthy lifestyle early in life offers the best long-term solution, many children and adolescents are currently at risk for future cardiovascular disease. Although long-term outcome data are lacking, the dyslipidemic triad commonly seen in youth with metabolic syndrome (elevated triglycerides, low high-density lipoprotein, and small dense low-density lipoprotein) is likely to significantly contribute to future vascular disease. Surrogate markers (carotid intima-media thickness and flow-mediated vasodilatation) for the precursors of cardiovascular disease are increased in obese youth, consistent with early vascular damage. In this work, we review the features of metabolic syndrome in children and adolescents, including age- and gender-specific norms for lipid values. Diagnostic criteria and modifications of screening guidelines unique to youth are discussed. Although recommendations for lifestyle modification are suggested for all, many youth at high risk of future cardiovascular risk may need more aggressive medical interventions to improve insulin sensitivity, achieve a less atherogenic lipid profile, and lower blood pressure.

Entities:  

Year:  2008        PMID: 21291733     DOI: 10.1016/j.jacl.2008.04.005

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  3 in total

1.  Obesity and metabolic syndrome and functional and structural brain impairments in adolescence.

Authors:  Po Lai Yau; Mary Grace Castro; Adrian Tagani; Wai Hon Tsui; Antonio Convit
Journal:  Pediatrics       Date:  2012-09-03       Impact factor: 7.124

2.  What is the most appropriate lipid profile ratio predictor for insulin resistance in each sex? A cross-sectional study in Korean populations (The Fifth Korea National Health and Nutrition Examination Survey).

Authors:  A Ri Byun; Sang Wha Lee; Hong Soo Lee; Kyung Won Shim
Journal:  Diabetol Metab Syndr       Date:  2015-06-28       Impact factor: 3.320

3.  Argan oil prevents prothrombotic complications by lowering lipid levels and platelet aggregation, enhancing oxidative status in dyslipidemic patients from the area of Rabat (Morocco).

Authors:  Adil Haimeur; Hafida Messaouri; Lionel Ulmann; Virginie Mimouni; Azelarab Masrar; Abdelmjid Chraibi; Gérard Tremblin; Nadia Meskini
Journal:  Lipids Health Dis       Date:  2013-07-20       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.